[The importance of benziodarone in the treatment of gout and hyperuricemic syndrome].

Article Details

Citation
Copy to clipboard

Linduskova M, Vykydal M

[The importance of benziodarone in the treatment of gout and hyperuricemic syndrome].

Cas Lek Cesk. 1990 Nov 30;129(48):1524-5.

PubMed ID
2257602 [ View in PubMed
]
Abstract

The authors pay attention to benziodarone, a representative of the category of benzofurans. They test its effect on the uric acid serum level in normouraemic subjects as well as in hyperuricaemic syndrome and gouty arthritis. The hypouricaemic action of benziodarone (Amplivex-Labaz) is prompt. The maximum drop of uricaemia after Amplivex administration (2 tablets/day) occurs during the first three days. The uric acid level declines by as much as 80% of the baseline value. For long-term treatment 1 tablet per day is sufficient, in some instances even 1 tablet twice a week. The tolerance of the preparation is satisfactory. The authors deal also with the mechanism of action of benziodarone. Amplivex is not only a uricostatic but also a uricosuric agent.

DrugBank Data that Cites this Article

Drugs